Provided by Tiger Trade Technology Pte. Ltd.

ETHZilla Corporation

3.19
-0.2400-7.00%
Post-market: 3.13-0.0600-1.88%19:03 EST
Volume:525.86K
Turnover:1.69M
Market Cap:60.41M
PE:-0.05
High:3.42
Open:3.36
Low:3.13
Close:3.43
52wk High:174.60
52wk Low:3.01
Shares:18.94M
Float Shares:15.13M
Volume Ratio:0.71
T/O Rate:3.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-68.6298
EPS(LYR):-154.9059
ROE:-96.47%
ROA:-27.79%
PB:0.14
PE(LYR):-0.02

Loading ...

Company Profile

Company Name:
ETHZilla Corporation
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
4
Office Location:
2875 South Ocean Blvd,Suite 200,Palm Beach,Florida,United States
Zip Code:
33480
Fax:
- -
Introduction:
180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed Phase IIb clinical trials that focuses on fibrosis and anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. 180 Life Sciences Corp. is headquartered in Palo Alto, California.

Directors

Name
Position
McAndrew Rudisill
Chief Executive Officer and Executive Chairman
Andrew Suckling
Director
Angela Dalton
Director
Crystal Heter
Director
Jason New
Director
Michael Edwards
Director
Ryan L. Smith
Director

Shareholders

Name
Position
McAndrew Rudisill
Chief Executive Officer and Executive Chairman
John Saunders
Chief Financial Officer